Countdown to Conference!
Companies Attending:
Enhance Efficacy, Durability, & Clinical Translation of Cell-Based & Antibody Targeted Innate Immune Therapies to Meet Global Unmet Patient Needs
October 17-19, 2023 | London
2nd Innate Killer Europe Summit 2023
Building Community and Collaboration to Leverage Innovative European R&D and Transform the Innate Immune Space
The momentum of innate immune cell R&D is growing exponentially to harness the innate immune system beyond NK cells and drive the development of gold-standard innate immune therapies. Now is the time to gather this vibrant community and build further collaboration at the centre of innovation: in Europe.
The 2nd Innate Killer Europe Summit gathers 80+ key European Gamma Delta T, NK,iNKT, neutrophil, and macrophage thought leaders in October to chase the holy grail of efficacious, off-the-shelf, innate immunotherapies through effective and scalable engineering, cell engager and combined modality strategies helping to bring safe, potent and persistent innate immune therapies to patients in need.
Seize your chance to network with innate immune pioneers from the likes of Sanofi, Mendus, Mink Therapeutics, Affimed, Carisma Therapeutics, Resolution Therapeutics, Treefrog Therapeutics and receive 3-days of some of the best scientific and data driven case studies that will help propel your innate immune therapy into the clinic and beyond.
Bridging the gap between next generation R&D innovation and clinical translation, this is the must-attend meeting to:
Navigate and foresee pre-clinical and CMC regulatory hurdles to accelerate future market access for innate cell therapies
Develop effective and scalable engineering, cell engager and combination strategies to overcome solid and hematological tumour resistance mechanisms
Harness the power of novel macrophage, iNKT and Neutrophil cell types to generate an endogenous immune response and achieve clinical success in oncology and beyond
World-Class Speaker Faculty Includes:
Helgi van de Velde
Vice President, Head of Hematologic Malignancies Strategies and Late Development
Sanofi
Hear What Our Past Attendees Have to Say:
Proud to Partner With:
Who's Attending?
